OBJECTIVE: Ovarian cancer is the third most common gynaecological cancer and has the high mortality rates and requires accurate intraoperative. Haptoglobin is an acute-phase protein locally elevated in cancer cells, may serve as a novel dia…
BACKGROUND: Vulvar masses present a diagnostic challenge due to their wide spectrum from benign lesions to malignancy. Mesonephric duct cysts are rare benign lesions derived from Wolffian duct remnants that may clinically mimic vulvar cance…
• Higher VAS scale is observed in those with adenomyosis. • Adenomyosis is associated with low progesterone environment. • IL-6, VEGF and COX-2 is found increased in adenomyosis. • Heightened inflammatory profile highlights the pro-inflamma…
BACKGROUND: Clear cell ovarian carcinoma (CCOC) is a type of epithelial ovarian cancer, representing 5-11% of ovarian cancers. CCOCs tend to occur in the fifth to seventh decades of life, with only 10% of cases occurring in the fourth decad…
Global challenges in ovarian cancer underscore the need for cost-effective screening. This study aims to assess the role of pretreatment Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte-Ratio (LMR), Platelet-to-Lymphocyte Ratio …
BACKGROUND: The correlation between endometrioma and serum Anti-mullerian hormone (AMH) level is a benchmark in determining the prognosis and management of endometrioma. Endometrioma causes a decrease in ovarian reserve due to tissue damage…